#Europe In Vitro Diagnostics Market Revenue | Explore Tumblr posts and blogs

neha24blog · 1 year ago

Text

Europe In Vitro Diagnostics Market Focusing On The Basis Of Product, Technology, Application, Test Location, Region And Forecasts To 2025 : Grand View Research Inc.

San Francisco, 23 May 2023: The Report Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technique (Immunology, Hematology, Clinical Chemistry, Coagulation, Microbiology, Molecular Diagnostics) By Application By End-use, And Segment Forecasts To 2024 The Europe IVD market is expected to reach over USD 15.5 billion by 2024…

View On WordPress

#Europe In Vitro Diagnostics Industry #Europe In Vitro Diagnostics Market #Europe In Vitro Diagnostics Market Revenue #Europe In Vitro Diagnostics Market Share #Europe In Vitro Diagnostics Market Size

0 notes

healthcaremarketanalysis · 24 days ago

Text

Allergy Diagnostics Industry worth $9.8 billion by 2029, with a CAGR of 11.0%

Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Download PDF Brochure

Browse in-depth TOC on “Allergy Diagnostics Market”

248 — Tables

57 — Figures

307 — Pages

The consumables segment is expected to account for the largest share in 2023.

The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience significant growth over the projected period. The increasing demand for rapid diagnosis of allergic patients which is driven by increasing number of allergic cases can be attributed for the larger share of this segment during the forecast period.

In Vivo test segment held the largest market share in the Allergy Diagnostics market.

Based on the test type, the Allergy Diagnostics market is segmented into in vivo tests and in vitro tests. In 2023, the in vivo tests segment accounted for the largest share of the Allergy Diagnostics market. The growth of this segment is mainly driven by the growing adoption of various in vivo tests, such as skin prick tests which is considered as the first line of diagnosis for allergy and favorable government support and guidelines.

Inhaled allergy segment held the largest market share in the Allergy Diagnostics market.

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2023, the inhaled allergens segment accounted for the largest share of the Allergy Diagnostics market due to the rising environmental pollution, rising home dust & mites coupled with other factors such as pollen, fungus, mold, and dust, and switching lifestyles, including rise in indoor activities and exposure to indoor allergen.

North America dominates the global Allergy Diagnostics market

Based on the region, the Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market is driven by availability of technologically advanced products and growing research on allergy by companies and government. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, lifestyle changes and climatic conditions, increased ozone and industrial pollution levels, and the rising demand for quality medical care are some of the major factors driving the growth of this regional market.

Request Sample Pages

Allergy Diagnostics Market Dynamics:

Drivers:

1. High incidence and heavy economic burden of allergic diseases

Restraints:

1. High pricing of allergy diagnostic instruments

Opportunities:

1. Integration of AI in allergy diagnosis

Challenge:

1. Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

· By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)

· By Designation: C-level (30%), Director-level (20%), and Others (50%)

· By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report:

Recent Developments of Allergy Diagnostics Industry:

· In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, “Minaris Medical”). After this share acquisition is finished, Minaris Medical — which runs companies that deal with automated analytical tools and in vitro diagnostic reagents — will be consolidated under Canon Medical.

· In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.

· In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Allergy Diagnostics Market — Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Allergy Diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

· Analysis of key drivers (global rise in prevalence and heavy economic burden of allergic illnesses, growing environmental pollution, and insurance coverage), restraints (high costs of analyzers and access is limited to healthcare services), opportunities (use of mHealth and integration of AI in allergy diagnosis), and challenges (a few number of allergists and challenges during diagnosis of allergy) influencing the growth of the Allergy Diagnostics market

· Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Allergy Diagnostics market.

· Market Development: Comprehensive information about lucrative markets — the report analyses the Allergy Diagnostics market across varied regions.

· Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Allergy Diagnostics market

· Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], among others in the Allergy Diagnostics market strategies.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1–888–600–6441

UK +44–800–368–9399

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

Content Source:

#Allergy Diagnostics Market #Inhaled Allergens Market Size #Food Allergens Market Share #Drug Allergens Market Growth

0 notes

communicationblogs · 2 months ago

Text

Cell Isolation/Cell Separation Market — Forecast(2024–2030)

Cell Isolation/Cell Separation Market Overview

Cell Isolation/Cell Separation Market Report Coverage

The report: “Cell Isolation/Cell Separation Market Forecast (2020–2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cell Isolation/Cell Separation Market.

By Product Type: Consumables and Instruments.

By Cell: Human Cell and Animal Cell.

By Technique: Filtration Based Cell Isolation, Centrifugation Based Cell Isolation and Surface Maker Based Cell Isolation.

By Application: Stem Cell Research, Cancer Research, Biomolecule Research, Vitro Diagnostics, Tissue Regeneration, Others.

By Geography: North America, Asia-Pacific, Europe, Rest of World (RoW).

SampleRequest

Key Takeaways

Geographically, North America Cell Isolation/Cell Separation Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020–2025 owing to the high demand.

The increase in the technology and awareness among customers is likely to aid in the market growth of Cell Isolation/Cell Separation Market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Cell Isolation/Cell Separation Market report.

The increase in the number of chronic diseases and increase in the demand for laboratory automation are creating higher opportunities for the growth of market for the forecast period 2020–2025.

By Service Type- Segment Analysis Based on the Service Type, the Repair and Maintenance segment held the largest share in 2019 owing to the factors such as rapid increase in the use of laboratory equipment for research activities and increase in the investment by the public and the private companies. Calibration segment is estimated to be the fastest growing segment during the forecast period 2020–2025. The growth in this segment is owing to the factors such as growing need for accurate and precise information, growing consciousness among customers and the government regulations.

Inquiry Before Buying

By End User- Segment Analysis

Based on the End User, the Clinical and Diagnostic Laboratories segment held the largest share in 2019 owing to the factors such as rapid increase in the research in drug discovery by the major companies, rapid increase in the number of diseases and growing awareness regarding health. Pharmaceutical and Biotechnological Companies segment is estimated to be the fastest growing segment owing to the factors such as increase in the demand for long-term treatment for chronic diseases, growing healthcare financial products and increase in the demand for generics market.

By Geography — Segment Analysis Based on the Geography, North America held the largest share in 2019. The growth in this segment is owing to the factors such as advancements in technology, rapid growth in the healthcare infrastructure and government policies supporting the developments in healthcare. Asia-Pacific is estimated to be the fastest growing segment owing to the factors such, as rapid increase in the import of laboratory equipment, investment by the major companies in the developing nations and growing research in pharmaceutical companies.

Schedule a Call

Cell Isolation/Cell Separation Market Drivers

Rapid increase in the research activities in the pharmaceutical and biotechnological industries.

The increase in the research activities in the pharmaceutical and biotechnological industries owing to rapid increase in the number of diseases, well developed infrastructures and advancements in technology is estimated to enhance the growth of Cell Isolation/Cell Separation Market. The increase in the demand for laboratory automation is also estimated to enhance the growth of Cell Isolation/Cell Separation Market.

Government’s policies to enhance biomedical research activities.

There is a rapid increase in the initiatives and policies by the governments towards biomedical research activities owing to growing awareness among customers increase in the number of aging population and growing prevalence of chronic diseases. This led to rapid increase in the growth of Cell Isolation/Cell Separation Market. Investments in the biotechnology sector and improvement in the healthcare infrastructure is also estimated to enhance the growth of the Cell Isolation/Cell Separation Market.

Buy Now

Cell Isolation/Cell Separation Market Challenges

The shift from lab-based diagnosis to home-based testing and high cost associated with the service contracts and raw material.

The shift from lab-based diagnosis to home-based testing owing to increase in the awareness among customers, decreasing the chances of complications and advancements in technology is estimated to reduce the growth of the Cell Isolation/Cell Separation Market. High costs associated with the service contracts and raw material is also said to reduce the growth of the Cell Isolation/Cell Separation Market.

Cell Isolation/Cell Separation Market Industry outlook: Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cell Isolation/Cell Separation Market. Key companies of this market are Agilent Technologies, Danaher Corporation, Pace Analytical Services, Thermo Fisher Scientific Inc, PerkinElmer Inc, Waters Corporation, Eppendorf AG, Siemens Healthineers, Abbott Laboratories, Bio-Rad Laboratories Inc among others.

Acquisitions/Product Launches:

In 2020, Agilent Technologies has launched CrossLab Connect Services for Lab-wide Asset Monitoring, which is an advanced service for laboratories seeking increased visibility and control over operations.

In 2020, Waters Corporation has launched the Waters ARC HPLC System to help laboratories meet quality and production targets and for routine testing in the pharmaceutical, food, academic and materials market.

For Information and report. Click Here

#reseach marketing #cell isolation market #marketing #digital marketing #Cell Separation

0 notes

globalgrowthinsights · 3 months ago

Text

Train Communication Gateways Systems Market Trends, Demand & Future Scope till 2032

Train Communication Gateways Systems Market provides in-depth analysis of the market state of Train Communication Gateways Systems manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Train Communication Gateways Systems in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Train Communication Gateways Systems Market Report:

The report offers a comprehensive and broad perspective on the global Train Communication Gateways Systems Market.

The market statistics represented in different Train Communication Gateways Systems segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Train Communication Gateways Systems are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Train Communication Gateways Systems.

Major stakeholders, key companies Train Communication Gateways Systems, investment feasibility and new market entrants study is offered.

Development scope of Train Communication Gateways Systems in each market segment is covered in this report. The macro and micro-economic factors affecting the Train Communication Gateways Systems Market

Advancement is elaborated in this report. The upstream and downstream components of Train Communication Gateways Systems and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/train-communication-gateways-systems-market-100575

Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Car Collision Avoidance Radar MarketMarket Growth

Membrane Pressure Vessel MarketMarket Analysis

In Vitro Diagnostics (IVD) Quality Control MarketMarket Size

Global Animal Drug Compounding MarketMarket Share

Global Polyhydroxyalkanoate (PHA) MarketMarket Growth

Digital Media MarketMarket

Domestic Booster Pump MarketMarket Share

Pv Solar Energy Charge Controller MarketMarket Growth Rate

Cloud Native Platform and Container Management Platforms MarketMarket Forecast

Global Artificial Intelligence in Agriculture MarketMarket Size

Face Mist MarketMarket Growth

Electric Power Distribution Equipment MarketMarket Analysis

Cloud ERP MarketMarket Size

Global Down Jacket MarketMarket Share

Global Laboratory Information System (LIS) MarketMarket Growth

Switch Mode Power Supply Transformers MarketMarket

Commercial Clothes Dryer MarketMarket Share

Podcasting MarketMarket Growth Rate

CBD Skin Care MarketMarket Forecast

Global Demand Side Platform (DSP) System MarketMarket Size

Collaborative Robot MarketMarket Growth

Fast Food and Quick Service Restaurant MarketMarket Analysis

Automotive Lifts & Car Parking Lifts MarketMarket Size

Global Active Electronically Scanned Array (AESA) Radars MarketMarket Share

Global Contact Lens MarketMarket Growth

Big Data in Power Sector MarketMarket

Floor Scrubber MarketMarket Share

Lighters MarketMarket Growth Rate

Prescription Pet Food MarketMarket Forecast

Global Skim Milk Powder (SMP) MarketMarket Size

Automatic Digital Cockpit IT Service MarketMarket Growth

Sapphire MarketMarket Analysis

Chloroprene Rubber (CR) MarketMarket Size

Global Electric Vehicle Charging Station MarketMarket Share

Global Molten Salt Solar Energy Thermal Storage and Concentrated Solar Power CSP MarketMarket Growth

Mechanical Microkeratome MarketMarket

Dual Teacher Teaching MarketMarket Share

Lighter MarketMarket Growth Rate

Three Season Sunroom MarketMarket Forecast

Global Amorphous Fe MarketMarket Size

0 notes

health-views-updates · 4 months ago

Text

Biomarkers Market Trends: Future Growth and Opportunities

Biomarkers Market Outlook, Scope & Overview:

Industry reports indicate that the global biomarkers market was valued at USD 81.10 billion in 2023 and is projected to reach USD 221.78 billion by 2031, growing at a CAGR of 13.4% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Biomarkers Market

The adoption of advanced biomarker technologies will continue to influence global market revenues. Healthcare providers and researchers are increasingly utilizing biomarkers to improve diagnostic accuracy, personalize treatment plans, and accelerate drug development processes.

As a product segment, diagnostic biomarkers currently hold a significant share of the global biomarkers market. This segment is anticipated to grow at a year-over-year rate of 13.4% in 2024 over 2023 and reach USD 221.78 billion in revenues by 2031. The increasing prevalence of chronic diseases, coupled with advancements in genomics and proteomics, is expected to drive market growth.

Get a Free Sample Report @ https://www.snsinsider.com/sample-request/3257

Biomarkers Solutions – Market Dynamics

Drivers:

Biomarker solutions are witnessing significant growth in the global market due to their ability to provide precise and early detection of diseases, enhance patient stratification, and facilitate targeted therapies. The growing adoption of personalized medicine, the rising incidence of cancer and other chronic conditions, and the increasing investment in biomarker research and development are key factors driving the adoption of biomarker solutions worldwide. Additionally, the expanding applications of biomarkers in drug discovery and development are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as high costs associated with biomarker discovery and validation, complex regulatory approval processes, and the need for advanced technological infrastructure are hindering the widespread adoption of biomarker solutions. Moreover, concerns about data privacy and the need for standardized biomarker assays pose additional challenges to market expansion.

Biomarkers Solutions – Market Outlook

The proven benefits of biomarker solutions in improving disease diagnosis, treatment outcomes, and drug development efficiency have contributed to the market's growth. Biomarker solutions are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in biotechnology and the growing focus on precision medicine.

Global Biomarkers Market

The rise in demand for biomarker solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global biomarkers market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of biomarker solutions, supported by favorable regulatory frameworks and increasing investments in biomedical research.

Key Players in the Biomarkers Solutions Market

Leading companies in the biomarkers solutions market include Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, and Abbott Laboratories. These companies are at the forefront of developing and commercializing advanced biomarker platforms for various applications, including diagnostics, drug development, and disease monitoring.

In conclusion, the global biomarkers market is poised for substantial growth over the forecast period, driven by technological advancements, increasing healthcare expenditures, and the expanding adoption of precision medicine and targeted therapies across diverse healthcare settings.

Other Trending Reports

MicroRNA Industry Growth

Palliative Care Industry Growth

Healthcare BPO Industry Growth

In Vitro Fertilization (IVF) Service Industry Growth

0 notes

giresearch · 4 months ago

Text

Medical Device Market Insights and Global Outlook 2024-2030

On 2024-7-4, the latest report 【Global Medical Device Market 2024 by Manufacturers, Regions, Types and Applications, Forecast to 2030】from Global Info Research provides a detailed and comprehensive analysis of the global Medical Device market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2024.

According to our (Global Info Research) latest study, the global Medical Device market size was valued at US$ 326220 million in 2023 and is forecast to a readjusted size of USD 479830 million by 2030 with a CAGR of 5.7% during review period. The key players of Medical Device include Medtronic, Johnson& Johnson, GE Healthcare and Abbott. The top four manufacturers hold approximately 18% of the global market share,. North America, Europe and China are the world's major production regions, with a combined market share of over 80%.In terms of application, Hospital has a share about 86 percent. This report is a detailed and comprehensive analysis for global Medical Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.

Medical Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type： In Vitro Diagnostics、Cardiology、Diagnostic Imaging、Orthopedics、Other

Market segment by Application：Hospital、Consumer

Major players covered：Medtronic、Johnson& Johnson、GE Healthcare、Abbott、Siemens Healthineers、Philips Health、Stryker、Becton Dickinson、Boston Scientific、Danaher、Zimmer Biomet、Alcon、B. Braun、Olympus、Terumo、Baxter、Smith & Nephew、Dentsply Sirona、Roche、Getinge、Edwards Lifesciences、Mindray、Shimadzu、Fujifilm、Hamilton Medical、Draeger、ResMed、Vyaire Medical

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Medical Device product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Medical Device, with price, sales quantity, revenue, and global market share of Medical Device from 2019 to 2024.

Chapter 3, the Medical Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Medical Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment Medical Device the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the Medical Device sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Device.

Chapter 14 and 15, to describe Medical Device sales channel, distributors, customers, research findings and conclusion.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Device

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

0 notes

healthcaremarketresearchsblog · 5 months ago

Text

In-Vitro Diagnostics Market Future Prediction Report By 2030

The Insight Partners recently announced the release of the market research titled In-Vitro Diagnostic Market Outlook to 2030 | Share, Size, and Growth. The report is a stop solution for companies operating in the In-Vitro Diagnostic market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. In-Vitro Diagnostic Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the In-Vitro Diagnostic market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated In-Vitro Diagnostic market research has all that you need.

What are Key Offerings Under this In-Vitro Diagnostic Market Research?

Global In-Vitro Diagnostic market summary, current and future In-Vitro Diagnostic market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global In-Vitro Diagnostic Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the In-Vitro Diagnostic Market?

In-Vitro Diagnostic market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. In-Vitro Diagnostic market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their In-Vitro Diagnostic market share.

Report Attributes

Details

Segmental Coverage

Product & Service

Reagents & Kits

Instruments

Software & Services

Technology

Immunoassay/ Immunochemistry

Clinical Chemistry

Molecular Diagnostics

Microbiology

Blood Glucose Self-Monitoring

Coagulation Hemostasis

Hematology

Urinalysis

Others

Application

Infectious Diseases

Diabetes

Oncology

Cardiology

Autoimmune Diseases

Nephrology

Others

End User

North America

Europe

Asia Pacific

the Middle East & Africa

South & Central America

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Abbott Laboratories?

F. Hoffmann-La Roche Ltd?

Danaher Corp?

Siemens AG?

Sysmex Corp?

Thermo Fisher Scientific Inc

Becton Dickinson and Co

bioMerieux SA?

Bio-Rad Laboratories Inc

Qiagen NV

Other key companies

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective In-Vitro Diagnostic market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The In-Vitro Diagnostic market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Author’s Bio:

Sunil Jadhav

Senior Market Research Expert at The Insight Partners

0 notes

bhushans · 6 months ago

Text

Meeting the Needs of a Growing Population: The Evolving Global Liquid Biopsy Market

The global liquid biopsy market is positioned for rapid expansion, with an estimated revenue of USD 1,538.3 million in 2023. According to insights from healthcare domain experts, providers in the liquid biopsy sector can anticipate a robust Compound Annual Growth Rate (CAGR) of 21.7% through 2033. By the end of the forecast period, the market is projected to achieve a valuation of USD 10,938.6 million, reflecting significant growth opportunities within the healthcare industry.

Liquid biopsy, a non-invasive diagnostic technique that detects biomarkers and genetic material in bodily fluids, is revolutionizing cancer diagnosis, monitoring, and treatment. This innovative approach offers several advantages over traditional tissue biopsy, including real-time monitoring, early detection of treatment response or resistance, and the ability to capture tumor heterogeneity

Tumor tissue is currently the gold standard for determining the kind and stage of cancer. Important players are attempting to reduce the current obstacles to its utilization in order to increase its potential applications in the future. The feasibility of liquid biopsy techniques for identifying cancer patients’ genetic profiles has also been shown by a number of research. The studies carefully take into account the reactions in order to track the course of treatment and identify any early warning symptoms of therapeutic resistance.

Request Your Detailed Report Sample With Your Work Email : https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

Liquid biopsies have become more common in recent years due to the desire for more personalized treatment options. Since liquid biopsy is widely available and reasonably priced in many labs, particularly in developing countries, its use is growing in popularity. For instance, several labs offer liquid biopsy tests.

“Key players are bringing cost reductions in liquid biopsy tests and partnering with local product distributors to strengthen their network base in target markets. Currently, a trend toward emerging economies has been spotted, as cancer cases are particularly on the rise, and a large population base provides significant opportunities in these markets,” says an FMI analyst.

Key Takeaways from the Liquid Biopsy Market Report

The North America liquid biopsy market is expected to account for a leading share of 50.84%. The United States is predicted to account for 43.8%, enjoying a dominant share in the global and regional markets.

The Europe market is anticipated to acquire a market share of 19.6% in 2023. Germany holds a prominent share in the region. In 2023, the country is predicted to amass a total of 6.6% share in the global market.

In Europe, the United Kingdom is predicted to expand at a robust CAGR of 26.4% through 2033.

In Asia Pacific, China and India display a remarkable percentage of growth, i.e., 29.7% and 24.4%, respectively, through 2033.

CTC (Circulating Tumor Cells) is projected to obtain a significant market share of 56.9% by biomarker type in 2023.

By sample type, blood sample type holds prominence in the liquid biopsy market.

Key Developments by Liquid Biopsy Market Players

QIAGEN N.V. (the Netherlands), in May 2022, introduced a therascreen EGFR Plus RGQ PCR Kit, which is a new in vitro diagnostic test for the analysis of sensitive EGFR mutation.

Guardant Health, Inc., in June 2021, introduced Guardant360 Response test that finds variations in circulating tumor DNA (ctDNA) levels.

Hoffmann-La Roche Ltd. (Switzerland), in October 2020, gained United States FDA approval for the extended claims for cobas EGFR Mutation Test v2 to be deployed as a companion diagnostic for an extensive range of therapies to manage non-small cell lung cancer (NSCLC).

Biocept, Inc., in March 2020, agreed with a California-based Independent Physician Association (IPA) to offer its Target Selector liquid assay services to patients and physicians in the network.

Key Companies Profiled:

BIOCEPT, INC.

Qiagen N.V.

Trovagene, Inc

Janssen Global Services, LLC

MDxHealth SA

Natera, Inc

F. Hoffmann-La Roche Ltd

Silicon Biosystems

Pathway Genomics Corporation

Sysmex Corporation

Others

Key Segments Profiled in the Liquid Biopsy Industry Survey:

By Biomarker Type:

CTCs (Circulating Tumour Cells)

ctNA (Circulating tumor Nucleic Acids)

Exosomes

By Sample Type:

Blood Liquid Biopsy

Urine Liquid Biopsy

Other (Plasma, Saliva, CSF) Liquid Biopsy

By Application Type:

Liquid Biopsy for Lung Cancer

Liquid Biopsy for Gastrointestinal Cancer

Liquid Biopsy for Prostate Cancer

Liquid Biopsy for Breast Cancer

Liquid Biopsy for Colorectal Cancer

Liquid Biopsy for Leukemia

By Region:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan

Japan

Middle East and Africa

#Liquid Biopsy Market

0 notes

adityarana1687-blog · 9 months ago

Text

In Vitro Diagnostics Market To Reach $101.58 Billion By 2030

The global in vitro diagnostics market size is expected to reach USD 101.58 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 4.4% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

Request a free sample copy or view the report summary: In Vitro Diagnostics Market Report

In Vitro Diagnostics Market Report Highlights

Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate

Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs

The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally

North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in vitro diagnostics (IVD) market report based on product, technology, application, end-use, test location, and region:

IVD Product Outlook (Revenue, USD Million, 2018 - 2030)

Instruments

Reagents

Services

IVD Technology Outlook (Revenue, USD Million, 2018 - 2030)

Immunoassay

Instruments

Reagents

Services

Hematology

Instruments

Reagents

Services

Clinical Chemistry

Instruments

Reagents

Services

Molecular Diagnostics

Instruments

Reagents

Services

Coagulation

Instruments

Reagents

Services

Microbiology

Instruments

Reagents

Services

Others

Instruments

Reagents

Services

IVD Application Outlook (Revenue, USD Million, 2018 - 2030)

Infectious Diseases

Diabetes

Oncology

Cardiology

Nephrology

Autoimmune Diseases

Drug Testing

Others

IVD Test Location Outlook (Revenue, USD Million, 2018 - 2030)

Point of Care

Home-care

Others

IVD End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Laboratory

Home-care

Others

IVD Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

Russia

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Singapore

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players of In Vitro Diagnostics (IVD) Market

Abbott

bioMérieux SA

QuidelOrtho Corporation

Siemens Healthineers AG

Bio-Rad Laboratories, Inc.

Qiagen

Sysmex Corporation

Charles River Laboratories

Quest Diagnostics Incorporated

Agilent Technologies, Inc.

Danaher Corporation

BD

F. Hoffmann-La Roche Ltd.

#In Vitro Diagnostics Market

0 notes

samutdbmr · 10 months ago

Text

Companion Animal Vaccines Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook

"Global Companion Animal Vaccines Market report puts light on analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally. This market research report performs an estimation of the growth rate and the market value based on market dynamics and growth inducing factors. Local, regional as well as global market has been considered here to conduct the research study of Companion Animal Vaccines Market report. The report can be accessible to the users in the form of PDF or spreadsheet. Moreover, PPT format can also be offered depending upon client’s requirement.

While preparing an outstanding Companion Animal Vaccines Market report, combination of best industry insight, practical solutions, talent solutions and latest technology have been utilized. The report aids in taking important decisions for the growth of business. What is more, with the utilization of best-practice models, comprehensive market analysis and research methodologies in this business report, it becomes simple to obtain perfect market segmentation and insights. The report also takes into consideration the detailed profiles of market’s major manufacturers and importers who are dominating the market. The world class Companion Animal Vaccines Market report enlists key competitors with the required specifications and also endows with the strategic insights and analysis of the main factors influencing the industry.

Access Full 350 Pages PDF Report @

Core Objective of Companion Animal Vaccines Market:

Every firm in the Companion Animal Vaccines Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

Size of the Companion Animal Vaccines Market and growth rate factors. Important changes in the future Companion Animal Vaccines Market. Top worldwide competitors of the Market. Scope and product outlook of Companion Animal Vaccines Market. Developing regions with potential growth in the future. Tough Challenges and risk faced in Market. Global Companion Animal Vaccinestop manufacturers profile and sales statistics.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Companion Animal Vaccines Market

Chapter 3: Regional analysis of the Global Companion Animal Vaccines Market industry

Chapter 4: Companion Animal Vaccines Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Regional Analysis for Companion Animal Vaccines Market:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) North America (U.S., Canada, and Mexico) South America (Brazil, Chile, Argentina, Rest of South America) MEA (Saudi Arabia, UAE, South Africa)

Browse Trending Reports:

In Vitro Diagnostics/IVD Market Trends, Share, Industry Size, Growth, Demand and Opportunities https://www.databridgemarketresearch.com/reports/global-in-vitro-diagnostics-ivd-market

Lower Back Pain Market Size, Share, Growth, Demand and Emerging Trends https://www.databridgemarketresearch.com/reports/global-lower-back-pain-market

C-Arms Market Emerging Trends and Opportunities https://www.databridgemarketresearch.com/reports/global-c-arms-market

Dental Bone Graft Market Trends, Share, Industry Size, Growth, Demand and Opportunities https://www.databridgemarketresearch.com/reports/global-dental-bone-graft-market

Offsite Sterilisation Service Market Trends, Share, Industry Size, Growth, Demand and Opportunities https://www.databridgemarketresearch.com/reports/global-offsite-sterilization-services-market

Smart Wheelchair Market Size, Share, Growth, Demand and Segments https://www.databridgemarketresearch.com/reports/global-smart-wheelchair-market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]"

0 notes

in-vitro-diagnostics-market · 1 year ago

Text

Top 5 Prominent Companies Shaping the In Vitro Diagnostics Market

The IVD market is driven by growing demand for point-of-care devices and rapid diagnostic testing, increasing prevalence of chronic diseases, and increasing willingness to pay for preventive care testing.

The global in vitro diagnostics market in terms of revenue was estimated to be worth $117.8 billion in 2022 and is poised to reach $138.4. billion by 2027, growing at a CAGR of 3.3% from 2022 to 2027.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

The prominent players in the IVD market are.

Roche diagnostics

Roche is a global pioneer in IVD focused on developing novel products with advanced research capabilities. The combined strengths of diagnostics & automation and growing expertise in personalized healthcare help the company acquire a prominent market share. The company’s differentiated product portfolio in infectious diseases, tissue diagnostics, oncology, and diabetes management, makes the company a leading player in the IVD market. Being a research-driven biotechnology company, Roche Diagnostics extensively invests in R&D. For instance, the company’s R&D expenditure accounted for USD 14.99 billion in 2021.

2. Danaher corporation

Danaher Corporation has established itself as a strong player in the IVD market. The company offers a wide array of products and services sold regularly through direct sales channels to a diverse customer base in more than 60 countries. As a multibillion-dollar global conglomerate, Danaher generates a large proportion of its sales in North America, Europe, and Asia/Australia.

During 2021, the Diagnostics segment experienced higher year-over-year sales for molecular diagnostics tests for COVID-19. Moreover, in 2021, core sales in the segment’s clinical lab business increased year-over-year across all major geographies, driven primarily by increased demand in the chemistry and immunoassay product lines. Additionally, in the same year, core sales in the molecular diagnostics business grew yearly in both developed and high-growth markets, contributing significantly to overall segment core sales growth. Sales in 2021 for the company’s diagnostics segment by region included-- 44% in North America, 19% in Western Europe, 5% in other developed markets, and 32% in high-growth markets.

3. ABBOTT LABORATORIES, INC.

Abbott Laboratories is a leading player in the IVD market. The company has a strong presence in the US and seeks to enhance its geographical presence by strengthening its business operations in emerging markets. The company has a strong product portfolio, and its FDA- and CE-approved products have helped it gain a sizable share of the IVD market. Abbott is presently focusing on developing next-generation instrument platforms, such as the PLEX-ID platform and other advanced patient self-testing technologies.

4. SIEMENS HEALTHINEERS

Siemens Healthineers is among the leading players in the IVD market. The company has a strong presence and scale and is directly represented in more than 70 countries worldwide, with primary production sites in the US, China, and Germany. Siemens provides a comprehensive array of IVDs spanning a breadth of test settings, from centralized reference and hospital laboratories to clinical and physician office laboratories. The company’s diagnostics business model is based on long-term contracts that include an initial instrument placement followed by ongoing reagent sales, which results in a predictive and resilient revenue stream.

In FY 2022, the company’s revenue increased notably across all segments on a comparable basis: Imaging by 5.8%, Varian by 6.5%, Advanced Therapies by 5.7%, and Diagnostics by 6.6%, including around USD 1.77 billion from rapid COVID-19 antigen tests.

5. SYSMEX CORPORATION

Sysmex’s business centers on IVD, especially hematology, urinalysis, and immunochemistry products. The company’s business spans over 190 countries. In IVD, Sysmex Corporation holds the 7th rank globally, the only top-10 company headquartered in Asia. Sysmex is a global leader in hematology products, holding more than 50% of the global hematology market.

Get 10% Free Customization on this Report: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=703

These five companies collectively shape the IVD market by consistently delivering innovative diagnostic solutions, playing a pivotal role in healthcare, and addressing the evolving diagnostic needs of patients and healthcare professionals.

#In Vitro Diagnostics #IVD #ivdmarket #healthcare

1 note · View note

healthcaremarketanalysis · 4 months ago

Text

Allergy Diagnostics Market worth $9.8 billion by 2029

Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Download an Illustrative overview:

Browse in-depth TOC on "Allergy Diagnostics Market"

248 - Tables

57 - Figures

307 – Pages